Inovio Pharmaceuticals Inc - Company & Market Research Reports

Inovio Pharmaceuticals is a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. The company has developed antigen-targeting immunotherapy and vaccine product candidates for HPV-caused precancers and cancers, breast, lung, pancreatic, and prostate cancer, hepatitis, HIV, influenza, Ebola, and other diseases. Inovio was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.


Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2018

  • Report
  • 265 Pages
From
Global HIV Infection Drug Market & Pipeline Insight - Product Thumbnail Image

Global HIV Infection Drug Market & Pipeline Insight

  • Drug Pipelines
  • 1350 Pages
From
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2017 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2017

  • Report
  • 980 Pages
From
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2017 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H1 2017

  • Report
  • 919 Pages
From
HIV / AIDS - Pipeline Review, H1 2016 - Product Thumbnail Image

HIV / AIDS - Pipeline Review, H1 2016

  • Report
  • 886 Pages
From
HIV-1 Infection - Pipeline Review, H2 2015 - Product Thumbnail Image

HIV-1 Infection - Pipeline Review, H2 2015

  • Report
  • 406 Pages
From
HIV / AIDS - Pipeline Review, H2 2015 - Product Thumbnail Image

HIV / AIDS - Pipeline Review, H2 2015

  • Report
  • 916 Pages
From
HIV / AIDS - Pipeline Review, H1 2015 - Product Thumbnail Image

HIV / AIDS - Pipeline Review, H1 2015

  • Report
  • 871 Pages
From
HIV-1 Infection - Pipeline Review, H1 2015 - Product Thumbnail Image

HIV-1 Infection - Pipeline Review, H1 2015

  • Report
  • 319 Pages
From
Global Human Papillomavirus Infection Drug Market & Clinical Trials Insight 2023 - Product Thumbnail Image

Global Human Papillomavirus Infection Drug Market & Clinical Trials Insight 2023

  • Report
  • 220 Pages
From
Hepatitis Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Hepatitis Drug Development Pipeline Review, 2017

  • Report
  • 209 Pages
From
2018 hepatitis C Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 hepatitis C Drug Development- Pipeline Analysis Report

  • Report
  • 200 Pages
From
Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Development Pipeline Review, 2018

  • Report
  • 82 Pages
From
Competitor Analysis: Human Papilloma Virus (HPV) Vaccines & Therapeutics - Product Thumbnail Image

Competitor Analysis: Human Papilloma Virus (HPV) Vaccines & Therapeutics

  • Report
  • 43 Pages
From
The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment - Product Thumbnail Image

The World Market for Cancer Therapeutics (Monoclonal Antibodies, TKIs, Vaccines, Cytokines, Gene Therapy, Chemotherapy, Others), Phase I- III Pipeline Analysis, Markets by Segment

  • Report
  • 320 Pages
From
HIV Vaccine Market Opportunity & Clinical Pipeline Analysis - Product Thumbnail Image

HIV Vaccine Market Opportunity & Clinical Pipeline Analysis

  • Report
  • 330 Pages
From
Global HIV Therapeutic & Preventive Vaccines Market - Segmented by Type and Geography 2017 - 2022 - Product Thumbnail Image

Global HIV Therapeutic & Preventive Vaccines Market - Segmented by Type and Geography 2017 - 2022

  • Report
  • 205 Pages
From
Competitor Analysis: Cancer Vaccines - Product Thumbnail Image

Competitor Analysis: Cancer Vaccines

  • Report
  • 179 Pages
From
Wilms Tumor Protein (WT33 or WT1) - Pipeline Review, H2 2017 - Product Thumbnail Image

Wilms Tumor Protein (WT33 or WT1) - Pipeline Review, H2 2017

  • Report
  • 66 Pages
From
Wilms Tumor Protein (WT33 or WT1) - Pipeline Review, H1 2017 - Product Thumbnail Image

Wilms Tumor Protein (WT33 or WT1) - Pipeline Review, H1 2017

  • Report
  • 66 Pages
From
Loading Indicator
adroll